Th17 cells Glucocorticoids Interferon IFN Cellules th17 Anticorps monoclonal Myoblasts Human myoblasts Exercise Interleukine-23 Acetylcholine receptors Auto-immunité CTCF PBMC Immunology and Microbiology Section Clinical cell transplantation Chronic inflammation Inflammation Immune regulation Genetics Cytokines Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Etiology Experimental autoimmune myasthenia gravis EAMG MYB Thymus LMNA Age Chemokine Interferon type-I Immunity MG patients Chemokines Centres germinatifs ectopiques Immune response Innate immunity FMR1 Gd T cells Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Acetylcholine receptor antibodies Experimental models Mass cytometry CyTOF Cardiomyopathy Ectopic germinal centers Quality of life Interleukin 23 Endogenous nucleic acids Complete Freund's adjuvant Conduction disease Interferonopathy Germinal centers Genetic associations Inflammatory cytokines Acetylcholine receptor Animal models AChR antibodies Macrophages CCL21 Interferon type I CD31 Early-onset myasthenia gravis Acides nucléiques endogènes Autoimmune diseases Neuromuscular junction Interferon de type I Ferrites COX2 Interferon-β M3243AG CXCL13-CXCR5 Disease susceptibility Chronicity Thymoma Antimir-150 Follicular hyperplasia Thymic epithelial cells Transcriptome Gender Adaptive immunity DICER BAFF Max Long-term follow-up Myasthenia Gravis MG Immunotherapy Heart failure Il-23 Maladie auto-immune Myasthénie grave Interféron de type I COVID-19 Interferon Myasthenia gravis B cells Lamin A/C nuclei Fragile X syndromes Autoimmunity Experimental autoimmune myasthenia gravis Experimental mouse models Germinal center Autoimmune disease